Clinical Trials and Translational Research Advisory Committee (CTAC)

The CTAC is an external oversight committee, governed by the provisions of the Federal Advisory Committee Act, that advises on the NCI-supported national clinical and translational research enterprises, including both intramural and extramural research. The committee is chaired by the NCI Director and members include leading authorities in clinical trials and translational research.  The CCCT Director serves as the Executive Secretary for CTAC and the CCCT staff facilitates operations.

Roles and responsibilities of the CTAC include:

• Oversees implementation of the CTWG and TRWG recommendations and initiatives, including evaluation system.
• Provides strategic advice regarding NCI’s entire clinical trials and translational research portfolios.
• Advises NCI on policies, procedures, processes, and tools that should be developed and implemented for prioritization, management, coordination, and administration of NCI-funded clinical trials and translational research.
• Advises the NCI Director on the status of NCI clinical trials and translational research projects across all Divisions, Offices, and Centers and makes recommendations for needed improvements.
• Provides a forum for the clinical trials and translational research communities to give advice directly to the NCI Director.

For information on CTAC’s membership, charter, function statement, and meeting schedule, agendas, and minutes, visit the CTAC’s web site.